NHS National Pharmaceuticals Transition 2022_1
Estimated value
£39.6m
Awarded value
£39.6m
Suppliers
1
Lots
1
Published
12 Aug 2022
Description
Invitation to offer for NHS National Pharmaceuticals Transition 2022_1 Offer reference number: CM/PHG/21/5637 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months. Potential periods of call-offs under the framework agreement: Transition: CESW: 29/07/2022 to 30/09/2023 (14 months) LSNE: 29/07/2022 to 31/05/2024 (22 months) NWLN: 29/07/2022 to 31/01/2023 (6 months) Oral (plus non-parenteral) Products: All regions: 29/07/2022 to 31/05/2024 (22 months) Hospital Only Products: CESW: 29/07/2022 to 30/09/2023 (14 months) LSNE: 29/07/2022 to 31/05/2024 (22 months) NWLN: 29/07/2022 to 31/01/2023 (6 months)
Scope
- Reference
- CF-1007100D0O000000rwimUAA
- Total value
- £39,636,345 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 28 Jul 2022 to 30 May 2024
- CPV classifications
- 33600000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 21 Apr 2022, 12:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£39.6m
Award date
18 Jul 2022
Contract start
28 Jul 2022
Contract end
30 May 2024